LORUS AND OHIO STATE UNIVERSITY TO COLLABORATE ON ACUTE MYELOID LEUKEMIA RESEARCH

Lorus Therapeutics Inc. ('Lorus'), a biopharmaceutical company specializing in the development and commercialization of pharmaceutical products and technologies for the management of cancer, today announced a research collaboration with Dr. Guido Marcucci, a prominent leukemia researcher and clinician at the Ohio State University Comprehensive Cancer Center, on a program of laboratory experiments on acute myeloid leukemia (AML) cell lines. These experiments, which will be conducted in both tissue culture and animal models, will provide important insights into the correlation between antitumor response and the cellular effects of GTI-2040 and cytarabine when given together.

Canada NewsWire Group (http://www.newswire.ca/en/releases/archive/September2005/07/c6379.html)